Literature DB >> 24806902

Quantification of urinary mevalonic acid as a biomarker of HMG-CoA reductase activity by a novel translational LC-MS/MS method.

Alison V M Rodrigues1, James L Maggs, Stephen J McWilliam, Munir Pirmohamed, Muireann Coen, Ian D Wilson, B Kevin Park, Daniel J Antoine.   

Abstract

BACKGROUND: Mevalonic acid (MVA), as a product of 3-hydroxy-3-methylglutaryl coenzyme A reductase, represents a potential multipurpose biomarker in health and disease. A translational urinary MVA quantification method was developed, validated and used to demonstrate the diurnal variation of urinary MVA excretion in rats and healthy children.
METHODS: Urinary MVA was converted to mevalonolactone at pH 2, extracted with ethyl acetate and quantified by reversed-phase liquid chromatography-tandem mass spectrometry.
RESULTS: The assay had a dynamic range of 0.0156-10 µg/ml with precision <15% CV, accuracy 85-115% and was transferred between laboratories. Urinary MVA excretion in rats and healthy children displayed a diurnal variation consistent with the known diurnal variation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.
CONCLUSION: Urinary MVA can be quantified accurately over a wide dynamic range by a validated translational and transferable method with biomarker capability.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24806902     DOI: 10.4155/bio.13.350

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  2 in total

1.  Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis.

Authors:  Peter Lundbäck; Pernilla Stridh; Lena Klevenvall; Rosalind E Jenkins; Marie Fischer; Erik Sundberg; Ulf Andersson; Daniel J Antoine; Helena Erlandsson Harris
Journal:  Antioxid Redox Signal       Date:  2015-02-06       Impact factor: 8.401

Review 2.  Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

Authors:  C M Mulders-Manders; A Simon
Journal:  Semin Immunopathol       Date:  2015-05-20       Impact factor: 9.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.